Cidara Therapeutics, Inc. — Form D

Cidara Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2015-02-17. The offering totals $42.0M, of which $42.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (39)

Showing 25 of 39 people.

NameRoleLocation
Dan BurgessDirectorSan Diego, CA
Steve ElmsDirectorNew York, NY
Patrick HeronDirectorPhiladelphia, PA
Kevin JudiceDirectorSouth San Francisco, CA
Nina KjellsonDirectorSanta Clara, CA
Scott RocklageDirectorMenlo Park, CA
Ted SchroederDirectorSan Diego, CA
Ken BartizalExecutive OfficerSan Diego, CA
Paul DaruwalaExecutive OfficerSan Diego, CA
Dirk ThyeExecutive OfficerSouth San Francisco, CA
Daniel D BurgessDirectorSacramento, CA
Carin R Canale-TheakstonDirectorSan Diego, CA
Laura R Tadvalkar, Ph.D.DirectorSan Diego, CA
Taylor R Sandison, M.D.Executive OfficerSan Diego, CA
Leslie R Tari, Ph.D.Executive OfficerSan Diego, CA
Preetam R Shah, Ph.D.Executive OfficerSan Diego, CA
Bonnie R Bassler, Ph.D.DirectorSan Diego, CA
James R Merson, Ph.D.DirectorSan Diego, CA
Ryan R SpencerDirectorSan Diego, CA
Shane R WardExecutive OfficerSan Diego, CA
Jeffrey Stein, Ph.D.DirectorSan Diego, CA
Jeffrey Stein, Ph.D.Executive OfficerSan Diego, CA
Kevin JudiceExecutive OfficerSouth San Francisco, CA
Jeffrey SteinDirectorSan Francisco, CA
Jeffrey SteinExecutive OfficerSan Francisco, CA

Other filings by this issuer (6)

FiledFormOfferingSold
2024-05-06D$240.0M$240.0M
2019-09-13D$9.0M$9.0M
2018-05-30D$1.9M$1.6M
2017-10-31D$20.2M$20.2M
2014-06-17D$42.7M$30.3M
2014-06-17D$6.0M$6.0M

More